General description
Prednisolone is a synthetic glucocorticoid used in the treatment of various conditions where corticosteroids are indicated.
INN
Prednisolone
Medicine type
Chemical agent
EML status history
First added in 1984
(TRS
722)
for
Allergic or hypersensitivity conditions of unspecified type
Added in 1984
(TRS
722)
for
Unspecified malignant neoplasms of ill-defined or unspecified sites
Added in 1989
(TRS
796)
for
Anterior uveitis
Added in 2011
(TRS
965)
for
Lymphoid leukaemia, not elsewhere classified
Added in 2011
(TRS
965)
for
Burkitt lymphoma including Burkitt leukaemia
Added in 2015
(TRS
994)
for
Follicular lymphoma
Added in 2015
(TRS
994)
for
Chronic lymphocytic leukaemia or small lymphocytic lymphoma
Added in 2015
(TRS
994)
for
Diffuse large B-cell lymphoma, not otherwise specified
Added in 2015
(TRS
994)
for
Hodgkin lymphoma
Removed in 2015
(TRS
994)
for
Unspecified malignant neoplasms of ill-defined or unspecified sites
Added in 2019
(TRS
1021)
for
Plasma cell myeloma
Added in 2019
(TRS
1021)
for
Malignant neoplasms of prostate
Changed in 2021
(TRS
1035)
for
Crohn disease site
Added in 2021
(TRS
1035)
for
Ulcerative colitis
Added in 2021
(TRS
1035)
for
Crohn disease site
Added in 2023
(TRS
1049)
for
Anaplastic large cell lymphoma, ALK-positive
Added in 2023
(TRS
1049)
for
Anaplastic large cell lymphoma, ALK-negative
Added in 2023
(TRS
1049)
for
Langerhans cell histiocytosis
Added in 2025
(TRS
1064)
for
Adrenocortical insufficiency
Added in 2025
(TRS
1064)
for
Trigeminal autonomic cephalalgias
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Antiallergics and medicines used in anaphylaxis
- Oral > Liquid: 5 mg per mL
- Oral > Solid: 5 mg; 25 mg
Section
Hormones and antihormones
- Oral > Solid: 5 mg; 25 mg
- Oral > Liquid: 5 mg per mL
Indications
Follicular lymphoma
Lymphoid leukaemia, not elsewhere classified
Chronic lymphocytic leukaemia or small lymphocytic lymphoma
Diffuse large B-cell lymphoma, not otherwise specified
Hodgkin lymphoma
Unspecified malignant neoplasms of ill-defined or unspecified sites
Burkitt lymphoma including Burkitt leukaemia
Plasma cell myeloma
Malignant neoplasms of prostate
Anaplastic large cell lymphoma, ALK-positive
Anaplastic large cell lymphoma, ALK-negative
Langerhans cell histiocytosis
Section
Ophthalmological preparations > Anti-inflammatory agents
- Local > Ophthalmological > Solution (eye drops): 0.5% (sodium phosphate)
Indications
Section
Anti-inflammatory medicines
- Local > Rectal > Retention enema: 20 mg per 100 mL (as sodium phosphate)
Indications
Section
Adrenal hormones and synthetic substitutes
- Oral > Solid > tablet: 1 mg
Indications
Section
Medicines for cluster headache
- Oral > Solid > tablet: 25 mg; 5 mg
Indications